Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol vs Homotaurine in MCI and APOE ε4 Carriers
NCT05022186Phase 4Unknown
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Apr 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cannabidiol, tramiprosate in Mild Cognitive Impairment (MCI), sponsored by Aristotle University of Thessaloniki. Status: unknown.
02
Drugs
cannabidioltramiprosate
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT05022186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022186.